Below is an assortment of blue-chip growth stocks based on the philosophy and research of Wharton finance professor Jeremy Siegel, author of Stocks for the Long Run.

Our aim was to find what Siegel calls "corporate El Dorados" - those golden firms that consistently reward investors year after year. In his 2005 book, The Future for Investors, he shows how companies that have marketed "tried and true" products for decades in slow-growth or even declining industries outperform firms that develop the hot new gizmos. Siegel endorses the stocks we uncovered using his approach.

Our 2006 growth-and-income stocks edged out the S&P with an average total return of 23%.

Company (Ticker symbol)	Current price	52-wk high	52-wk low	Market Cap (mill)	Div Yield	P/E Ratio	Earnings growth
Abbott Labs (ABT)	$53.71	$57.39	$41.27	$83,075.30	3.0%	21.8	11%
Altria (MO)	$19.31	$19.48	$14.42	$40,014.39	7.0%	13.8	8%
Coca-Cola (KO)	$57.60	$58.43	$37.44	$133,469.63	2.9%	21.2	9%
Colgate-Palmolive (CL)	$85.23	$87.39	$54.51	$42,375.59	2.1%	22.4	11%
General Mills (GIS)	$68.92	$69.10	$46.37	$22,508.10	2.7%	18.8	8%
Johnson & Johnson (JNJ)	$64.34	$64.73	$46.25	$177,520.49	3.0%	15.8	9%
Procter & Gamble (PG)	$62.55	$64.00	$43.93	$182,754.46	2.8%	21.6	11%
Current price, 52-week high/low and market cap as of Dec 04 16:00 P/E based on earnings for the last 12 months. Earnings growth based on analyst projections for the next five years, according to Baseline.